Showing results (1581-1590 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|March 10, 2015
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized studyVéronique Diéras, Hans Wildiers, Jacek Jassem, et al.Breast (Edinburgh, Scotland)|March 25, 2015
Sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with breast cancer: Are the current false negative rates acceptable?D K Patten, K E Zacharioudakis, H Chauhan, et al.Breast (Edinburgh, Scotland)|July 28, 2012
The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030Fatemeh Asadzadeh Vostakolaei, Mireille J M Broeders, S Mohsen Mousavi, et al.Breast (Edinburgh, Scotland)|October 24, 2012
Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acidJason Young, Nancy A Nickman, Joseph E Biskupiak, et al.Breast (Edinburgh, Scotland)|October 25, 2012
Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: a review of the literatureKimberly A Boswell, Xufang Wang, Manasee V Shah, et al.Breast (Edinburgh, Scotland)|January 28, 2015
Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer studyL Fallowfield, S Osborne, C Langridge, et al.Breast (Edinburgh, Scotland)|July 17, 2012
Trends in tertiary breast reconstruction: literature review and single centre experienceAnita T Mohan, Yazan Al-Ajam, Afshin MosahebiBreast (Edinburgh, Scotland)|April 18, 2015
Breast cancer brain metastases - A 12 year review of treatment outcomesP B De Ieso, U Schick, N Rosenfelder, et al.Breast (Edinburgh, Scotland)|February 24, 2015
2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practiceIlaria Pennacchia, Arnaldo Carbone, Arcangelo Di Cerbo, et al.Breast (Edinburgh, Scotland)|April 26, 2021
A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropeniaMark Clemons, Dean Fergusson, Anil A Joy, et al.Pageof 366